Benjamin Felkel

Roche Pharma AG (Germany)

Papers

1

Total Citations

3

H-Index

1

About

Dr. Benjamin Felkel is a leading expert in biopharmaceutical formulation science, with a primary focus on the stability and quality control of therapeutic proteins. His key research areas center on surfactant degradation, specifically the hydrolytic breakdown of polysorbates—a critical challenge in the pharmaceutical industry. Dr. Felkel’s major contribution is the development of "High throughput FAMS – A fatty acid mass spectrometry method for monitoring polysorbate hydrolysis in QC," a pioneering analytical technique that enables rapid, high-throughput detection of free fatty acids. This method directly addresses the industry-wide problem of visible particle formation caused by polysorbate degradation, offering a robust solution for quality control in biopharmaceutical manufacturing. His work has garnered significant attention, with his most-cited paper accumulating 3 citations since 2023, reflecting its immediate relevance to technical development teams. Dr. Felkel’s research has been instrumental in advancing our understanding of surfactant stability, providing a practical tool to ensure product safety and efficacy. His achievements underscore a commitment to bridging analytical chemistry with real-world pharmaceutical challenges, making him a valuable resource for students and researchers exploring formulation science and protein stability.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
High throughput FAMS – A fatty acid mass spectrometry method for monitoring polysorbate hydrolysis in QC
3 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Roche Pharma AG (Germany)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago